Clarity Pharmaceuticals Ltd.ASX: CU6

Becoming a substantial holder

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX ·

603 Page 1 30-Jul-2026 To Company Name/Scheme ACN/ARSN 1. Details of substantial holder (1) Name ACN/ARSN (if applicable) The holder became a substantial holder on 28/07/2026 2. Details of voting power The total number of votes attached to all the voting shares in the company or voting...

View Attachment

6ix hasn’t read this filing yet.

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

Later from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases